Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Lymphoma, T Cell, Peripheral

fluorodeoxyglucose f18 has been researched along with Lymphoma, T Cell, Peripheral in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (16.13)29.6817
2010's18 (58.06)24.3611
2020's8 (25.81)2.80

Authors

AuthorsStudies
Chen, D; Hu, Y; Tan Su Yin, E; Wang, G; Wang, H; Zhang, Y; Zhao, K; Zhao, X1
Tang, P; Tian, R; Yang, G; Zhang, Y1
Huang, M; Shen, G; Tian, R; Wang, R1
Ding, C; Jiang, C; Teng, Y; Xie, Y; Zhou, Z1
Ahn, JS; Ahn, SY; Han, YH; Jung, SH; Jung, SY; Kang, SR; Kim, HJ; Kwak, JY; Lee, JJ; Yang, DH; Yhim, HY1
Alashkar, F; Behringer, D; Bengel, FM; Bernhard, H; Boellaard, R; Brenner, W; Brinkmann, M; Dührsen, U; Dürk, H; Franzius, C; Freesmeyer, M; Ganser, A; Giagounidis, A; Haberkorn, U; Hautzel, H; Heike, M; Heil, G; Hertel, A; Hertenstein, B; Hoeffkes, HG; Hoelzer, D; Hüttmann, A; Jöckel, KH; Klapper, W; Kotzerke, J; Kreisel-Büstgens, C; Krohn, T; Kroschinsky, F; Kurch, L; La Rosée, P; Larisch, R; Mahlmann, S; Martens, U; Mesters, R; Moeller, R; Müller, SP; Prange-Krex, G; Rekowski, J; Runde, V; Sandmann, M; Schmitz, C; Trenn, G; Wacker, D; Weckesser, M; Wilop, S1
Allmer, C; Cerhan, JR; Habermann, TM; Harper, L; Higgins, A; Johnston, P; Kim, H; Maurer, MJ; Nowakowski, GS; Thanarajasingam, G; Thompson, CA; Witzig, TE; Young, JR1
Barrington, SF; Trotman, J1
Bae, H; Ito, I; Kubota, K; Nagahama, F; Okamoto, T; Sonehara, Y; Tateishi, U; Tsuchiya, J1
Bantilan, K; Horwitz, SM; Ito, K; Mehta-Shah, N; Moskowitz, AJ; Sauter, C; Schöder, H1
Colletti, PM; Rubello, D1
Abe, Y; Kitadate, A; Kobayashi, H; Matsue, K; Miura, D; Narita, K; Oʼuchi, E; Oʼuchi, T; Takeuchi, M; Usui, Y1
Fang, Y; Huang, WT; Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, H; Zhang, WJ; Zheng, R1
Cui, Y; Dong, A; Wang, Y; Zuo, C1
Cashen, A; Liu, J; Shea, L1
Fujisawa, S; Hashimoto, C; Hattori, Y; Ishigatsubo, Y; Sakai, R; Taguchi, J; Takasaki, H; Tateishi, U; Tomita, N1
Collins, GP; Corcoran, JP; Davies, SJ; Ho, LP; Moore, AJ1
Balser, B; Balser, J; Caballero, D; Coiffier, B; Foss, F; Greenwood, M; Horwitz, S; Iyer, SP; Morschhauser, F; Nichols, J; Pinter-Brown, L; Prince, HM; Pro, B; Shustov, A; Sokol, L1
Ahn, JS; Bom, HS; Byun, BH; Chae, YS; Do, YR; Jung, SH; Kim, HJ; Kim, YK; Kweon, SS; Lee, JJ; Lee, SW; Min, JJ; Moon, JH; Sohn, SK; Yang, DH1
Bøgsted, M; de Nully Brown, P; El-Galaly, TC; Gang, AO; Gormsen, LC; Hendel, HW; Hutchings, M; Iyer, V; Loft, A; Madsen, J; Mylam, KJ; Nielsen, AL; Pedersen, MB1
Blaise, D; Bouabdallah, R; Broussais, F; Charrier, N; Coso, D; El Cheikh, J; Granata, A; Saillard, C; Schiano, JM1
Becker, S; Bertrand, S; Bonnet, C; Broussais, F; Casasnovas, O; Charrier, N; Cottereau, AS; de Leval, L; Delarue, R; Gaulard, P; Haioun, C; Hustinx, R; Itti, E; Kanoun, S; Meignan, M; Mounier, N; Roques, M; Tilly, H; Vera, P1
Dong, A; Gong, J; Jing, W; Wang, L; Wang, Y; Yang, P; Zhang, X1
Broski, SM; Feldman, AL; Habermann, TM; Jevremovic, D; Maurer, MJ; Pham, AQ; Ristow, KM; Wiseman, GA; Witzig, TE1
Alavi, A; Basu, S; Cermik, TF; Dhuriraj, T; Kumar, R; Mavi, A; Torigian, D; Urhan, M; Wasik, M1
Chen, JT; Chen, YJ; Gao, HW; Lu, DW; Tai, MC1
Balon, H; Douglas-Nikitin, V; Khong, PL; Tang, B; Wong, CO; Wong, CY1
Ciarallo, A; Derbekyan, V; Makis, W1
Hatano, Y; Hayashi, Y; Hirose, Y; Hozumi, I; Inuzuka, T; Kasahara, S; Kato, J; Kimura, A; Koumura, A; Moriwaki, H; Nakamura, H; Sakurai, T; Takami, T; Tanaka, Y; Tsurumi, H; Yamada, M1
Juweid, ME1
Armitage, JO; Bishu, S; Bishu, SR; Hankins, JH; Holdeman, KH; Olsasky, SM; Paknikar, S; Quigley, JM; Schmitz, J; Stemm, RA1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Lymphoma, T Cell, Peripheral

ArticleYear
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma.
    The Lancet. Haematology, 2021, Volume: 8, Issue:1

    Topics: Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography

2021

Trials

3 trial(s) available for fluorodeoxyglucose f18 and Lymphoma, T Cell, Peripheral

ArticleYear
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas.
    Annals of hematology, 2020, Volume: 99, Issue:1

    Topics: Adult; Autografts; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed

2020
Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multice
    Japanese journal of radiology, 2018, Volume: 36, Issue:11

    Topics: Aged; Arsenicals; Asia; Biomarkers; Female; Fluorodeoxyglucose F18; Glutathione; Humans; Internationality; Japan; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; North America; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radiology; Radiopharmaceuticals; Reference Standards; Societies, Medical; Treatment Outcome

2018
Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:4

    Topics: Antibiotics, Antineoplastic; Depsipeptides; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Survival Rate; Tissue Distribution

2015

Other Studies

27 other study(ies) available for fluorodeoxyglucose f18 and Lymphoma, T Cell, Peripheral

ArticleYear
The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS).
    BMC medical imaging, 2021, 10-09, Volume: 21, Issue:1

    Topics: Adult; Aged; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, T-Cell, Peripheral; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate

2021
Osteoblastoma of the Rib Mimicking Lymphomatous Involvement on 18F-FDG PET/CT Imaging.
    Clinical nuclear medicine, 2022, May-01, Volume: 47, Issue:5

    Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Middle Aged; Neoplasm Staging; Osteoblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed

2022
Nasal-Type NK/T-Cell Lymphoma Involvement of the Vocal Cord on FDG PET/CT.
    Clinical nuclear medicine, 2022, Oct-01, Volume: 47, Issue:10

    Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell, Peripheral; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Vocal Cords

2022
Prognostic value of 18F-FDG lesion dissemination features in patients with peripheral T-cell lymphoma (PTCL).
    Japanese journal of radiology, 2023, Volume: 41, Issue:7

    Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden

2023
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
    Hematological oncology, 2020, Volume: 38, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Young Adult

2020
Testicular FDG-PET/CT uptake threshold in aggressive lymphomas.
    American journal of hematology, 2021, 03-01, Volume: 96, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Burkitt Lymphoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Testis; Young Adult

2021
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma.
    Blood advances, 2019, 01-22, Volume: 3, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Vincristine

2019
Re: Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:10

    Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals

2019
Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:5

    Topics: Adolescent; Adult; Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Factors

2019
[Correlation of ¹⁸F-FDG uptake with tumor-proliferating antigen Ki-67 expression in aggressive lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:5

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies

2013
FDG PET/CT findings in 3 cases of pulmonary peripheral T-cell lymphoma.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:4

    Topics: Fluorodeoxyglucose F18; Humans; Lung; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed

2014
Prognostic significance of [18F]fluorodeoxyglucose-positron emission tomography in peripheral T-cell lymphoma treated with stem cell transplantation: a retrospective analysis.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:1

    Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography; Prognosis; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome

2015
Post-therapy ¹⁸F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma.
    Annals of hematology, 2015, Volume: 94, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron-Emission Tomography; Prednisolone; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine

2015
A 72-year-old woman with a persistent cough and abnormal chest X-ray.
    British journal of hospital medicine (London, England : 2005), 2014, Volume: 75, Issue:11

    Topics: Aged; Antinematodal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2014
Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.
    BMC cancer, 2015, Mar-28, Volume: 15

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2015
Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients.
    American journal of hematology, 2015, Volume: 90, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Vincristine

2015
Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzofurans; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lymphoma, T-Cell, Peripheral; Positron Emission Tomography Computed Tomography; Recurrence; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome

2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Tumor Burden

2016
Primary Uterine Peripheral T-cell Lymphoma: A Case Report of MRI and 18F-FDG PET/CT Findings.
    Medicine, 2016, Volume: 95, Issue:17

    Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphoma, T-Cell, Peripheral; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Uterine Neoplasms; Uterus

2016
Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issue.
    Leukemia & lymphoma, 2017, Volume: 58, Issue:10

    Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity

2017
Central photopenic lesions on FDG-PET scan in a patient with peripheral T cell lymphoma.
    Annals of nuclear medicine, 2008, Volume: 22, Issue:7

    Topics: Alcoholism; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Biomarkers, Tumor; Biopsy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging

2008
Primary peripheral T-cell lymphoma of the orbit.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:8

    Topics: Adult; Female; Fluorodeoxyglucose F18; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Lymphoma, T-Cell, Peripheral; Orbital Neoplasms; Polymerase Chain Reaction; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Antigen, T-Cell, gamma-delta; Tomography, X-Ray Computed

2009
Exceptionally low metabolic activity in aggressive peripheral T-cell lymphoma.
    Nuclear medicine communications, 2009, Volume: 30, Issue:11

    Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography; Tomography, X-Ray Computed

2009
Primary peripheral T-cell lymphoma of the colon mimics inflammatory bowel disease: a potential pitfall with F-18 FDG PET/CT imaging.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:7

    Topics: Colon; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel Diseases; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging

2011
Diffuse skeletal muscles uptake of [18F] fluorodeoxyglucose on positron emission tomography in primary muscle peripheral T-cell lymphoma.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:18

    Topics: Adult; Biological Transport; Biopsy; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Positron-Emission Tomography

2011
Peripheral T-cell lymphomas: variably or routinely fluorodeoxyglucose-avid?
    Leukemia & lymphoma, 2007, Volume: 48, Issue:8

    Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome

2007
F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome

2007